Catalent expands biologics manufacturing operations in Bloomington, Indiana

Catalent commenced a significant expansion of its biologics manufacturing operations in Bloomington, Indiana, with plans to create up to 200 new jobs by 2024 and invest over $100 million, including $14 million for packaging expansion.

“Catalent plans to invest over $100 million in its Bloomington operations, growing the site’s packaging capabilities and manufacturing capacity to support customers’ clinical pipeline and commercial launches.”iedc.in.gov

• 1 source
• iedc.in.govCatalentJan 7, 2019

Summarized from public sources; check the original articles before acting on it.